BioPharmSignal logoBioPharmSignal

Biotech News

embecta Announces Quarterly Cash Dividend

Embecta (EMBC)EmbectaCompany update

PARSIPPANY, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.01 for each issued and outstanding share of the Company’s common stock. The dividend is payable on June 15, 2026 to stockholders of

Open original release

Related news

EMBCEmbecta2026-06-01 21:00 EST

embecta to Participate in Investor Events

EMBCEmbecta2026-05-15 13:00 EST

embecta Completes Acquisition of Owen Mumford Holdings Limited

View all latest news

Embecta

Embecta is a diabetes care company built around insulin delivery devices and related consumables. Its story is less about broad biotech innovation and more about recurring demand in chronic disease management.

Recent company news

EMBCEmbecta2026-06-01 21:00 EST

embecta to Participate in Investor Events

EMBCEmbecta2026-05-15 13:00 EST

embecta Completes Acquisition of Owen Mumford Holdings Limited

EMBCEmbecta2026-05-08 13:00 EST

embecta to Participate at the 2026 BofA Securities Global Health Care Conference

EMBCEmbecta2026-05-05 10:30 EST

Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results

EMBCEmbecta2026-05-05 10:30 EST

embecta Announces Quarterly Cash Dividend

Stock data

Close
3.44 USD
Market cap
207.05M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States